From the Vendor: Fasoracetam is a nootropic compound in the racetams group. Fasoracetam (N-(5-Oxo-D-prolyl)piperidine) (ref)* and its mechanism of action is not fully understood at this time.
The pre-clinical animal studies, which may not be representative of the effects in humans, indicate that Fasoracetam modulates and activates the metabotropic glutamate receptors (mGluR) (2)*. Pre-clinical animal studies demonstrate Fasoracetam’s ability to increase acetylcholine release, uptake, and GABAb (3).*
Since its development in the 1990s in Japan, Fasoracetam studies and human clinical trials have been underway and have demonstrated its safety profile is well tolerated (2)*.
Assured Purity: Rigorously tested for quality & purity by third-party Certificate of Analysis*